Drugs Made In America Acquisition II (DMII) Institutional Ownership $10.04 +0.01 (+0.10%) As of 03:58 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Drugs Made In America Acquisition II (NASDAQ:DMII)Number ofInstitutional Buyers(last 12 months)42TotalInstitutional Inflows(last 12 months)$31.41MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$749.80K Get DMII Insider Trade Alerts Want to know when executives and insiders are buying or selling Drugs Made In America Acquisition II stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data DMII Institutional Buying and Selling by Quarter Drugs Made In America Acquisition II Major Shareholders & Ownership History ExportReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/18/2026 Rivernorth Capital Management LLC300,000$2.99M0.2%N/A0.000% 5/18/2026 Royal Bank of Canada40,994$409K0.0%-38.1%0.000% 5/15/2026 Sona Asset Management US LLC500,000$4.99M0.1%+66.7%0.000% 5/15/2026 Kryger Capital LLC309,729$3.09M0.2%N/A0.000% 5/14/2026 Healthcare of Ontario Pension Plan Trust Fund2,000,000$19.96M0.0%N/A0.000% 5/14/2026 Gabelli Funds LLC161,400$1.61M0.0%N/A0.000% 5/14/2026 GABELLI & Co INVESTMENT ADVISERS INC.179,500$1.79M0.3%N/A0.000% 5/1/2026 Commonwealth of Pennsylvania Public School Empls Retrmt SYS350,000$3.49M0.0%-12.5%0.000% 2/26/2026 Lineage Point Capital LP336,360$3.33M1.3%N/A0.000% 2/23/2026 Virtu Financial LLC31,991$317K0.0%N/A0.000% Get the Latest News and Ratings for DMII and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Drugs Made In America Acquisition II and its competitors with MarketBeat's FREE daily newsletter. 2/18/2026 TENOR CAPITAL MANAGEMENT Co. L.P.1,500,000$14.85M0.2%N/A0.000% 2/18/2026 Toronto Dominion Bank189,909$1.88M0.0%N/A0.000% 2/18/2026 Sona Asset Management US LLC300,000$2.97M0.1%N/A0.000% 2/18/2026 Millennium Management LLC1,500,000$14.85M0.0%N/A0.000% 2/18/2026 Moore Capital Management LP750,000$7.43M0.1%N/A0.000% 2/18/2026 Aristeia Capital L.L.C.1,100,000$10.89M0.2%N/A0.000% 2/17/2026 AQR Arbitrage LLC1,151,400$11.40M0.2%N/A0.000% 2/17/2026 Polar Asset Management Partners Inc.1,500,000$14.85M0.2%N/A0.000% 2/17/2026 HBK Investments L P500,000$4.95M0.0%N/A0.000% 2/17/2026 Ghisallo Capital Management LLC750,000$7.43M0.3%N/A0.000% 2/17/2026 Radcliffe Capital Management L.P.575,607$5.70M0.3%N/A0.000% 2/17/2026 Royal Bank of Canada66,200$655K0.0%N/A0.000% 2/17/2026 Magnetar Financial LLC2,700,000$26.73M0.3%N/A0.000% 2/16/2026 OMERS ADMINISTRATION Corp1,000,000$9.90M0.1%N/A0.000% 2/16/2026 Sculptor Capital LP500,000$4.95M0.1%N/A0.000% 2/16/2026 Verition Fund Management LLC200,000$1.98M0.0%N/A0.000% 2/16/2026 PEAK6 LLC100,000$990K0.0%N/A0.000% 2/16/2026 Clear Street Group Inc.181,521$1.80M0.0%N/A0.000% 2/16/2026 Context Capital Management LLC750,000$7.43M0.2%N/A0.000% 2/13/2026 Westchester Capital Management LLC500,000$4.95M0.2%N/A0.000% 2/13/2026 DLD Asset Management LP112,200$1.11M0.1%N/A0.000% 2/13/2026 Hudson Bay Capital Management LP1,969,030$19.49M0.1%N/A0.000% 2/13/2026 Quarry LP100,000$990K0.2%N/A0.000% 2/13/2026 Glazer Capital LLC2,349,899$23.26M0.6%N/A0.000% 2/13/2026 First Trust Capital Management L.P.2,068,118$20.47M1.2%N/A0.000% 2/12/2026 Mint Tower Capital Management B.V.250,000$2.48M0.3%N/A0.000% 2/11/2026 Picton Mahoney Asset Management875,000$8.66M0.1%N/A0.000% 2/10/2026 Periscope Capital Inc.265,500$2.63M0.3%N/A0.000% 2/10/2026 Commonwealth of Pennsylvania Public School Empls Retrmt SYS400,000$3.96M0.0%N/A0.000% 2/9/2026 Geode Capital Management LLC26,801$265K0.0%N/A0.000% Before you buy SpaceX shares, consider this alternative approach (Ad)SpaceX has confidentially filed for an IPO with the SEC, targeting a June 2026 listing at a valuation exceeding $1.75 trillion - potentially the largest IPO in history. But one expert says buying shares directly may not be the smartest move. There is a lesser-known way to tap into this windfall that most investors haven't considered.Discover the overlooked SpaceX IPO strategy before the June listing2/6/2026 HighTower Advisors LLC789,614$7.82M0.0%N/A0.000% 2/5/2026 Wealthspring Capital LLC408,950$4.05M1.0%N/A0.000% 2/4/2026 ABC Arbitrage SA40,000$396K0.0%N/A0.000% 2/2/2026 Wolverine Asset Management LLC1,062,773$10.52M0.1%N/A0.000% 1/29/2026 Deltec Asset Management LLC50,000$495K0.1%N/A0.000% DMII Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of DMII shares? During the previous two years, 42 institutional investors and hedge funds held shares of Drugs Made In America Acquisition II. The most heavily invested institutionals were Magnetar Financial LLC ($26.73M), Glazer Capital LLC ($23.26M), First Trust Capital Management L.P. ($20.47M), Healthcare of Ontario Pension Plan Trust Fund ($19.96M), Hudson Bay Capital Management LP ($19.49M), Millennium Management LLC ($14.85M), and TENOR CAPITAL MANAGEMENT Co. L.P. ($14.85M).Learn more on Drugs Made In America Acquisition II's institutional investors. Which institutional investors have been buying Drugs Made In America Acquisition II's stock? Of the 42 institutional investors that purchased Drugs Made In America Acquisition II's stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Magnetar Financial LLC ($2.70M), Glazer Capital LLC ($2.35M), First Trust Capital Management L.P. ($2.07M), Healthcare of Ontario Pension Plan Trust Fund ($2M), Hudson Bay Capital Management LP ($1.97M), Millennium Management LLC ($1.50M), and Polar Asset Management Partners Inc. ($1.50M). How much institutional buying is happening at Drugs Made In America Acquisition II? Institutional investors have bought a total of 30,101,502 shares in the last 24 months. This purchase volume represents approximately $31.41M in transactions. Which of Drugs Made In America Acquisition II's major shareholders have been selling company stock? The following institutional investors have sold Drugs Made In America Acquisition II stock in the last 24 months: Commonwealth of Pennsylvania Public School Empls Retrmt SYS ($50K), and Royal Bank of Canada ($25.21K). How much institutional selling is happening at Drugs Made In America Acquisition II? Institutional investors have sold a total of 75,206 shares in the last 24 months. This volume of shares sold represents approximately $749.80K in transactions. Related Companies 1RT Acquisition Institutional Ownership A SPAC III Acquisition Institutional Ownership AGNC Investment Institutional Ownership Agriculture & Natural Solutions Acquisition Institutional Ownership Aimei Health Technology Institutional Ownership Alchemy Investments Acquisition Corp 1 Institutional Ownership Aldel Financial II Institutional Ownership Aldel Financial II Institutional Ownership Aparadise Acquisition Institutional Ownership Archimedes Tech SPAC Partners II Institutional Ownership This page (NASDAQ:DMII) was last updated on 5/19/2026 by MarketBeat.com Staff. From Our PartnersSpaceX eyes a 1.75 trillion valuation - here's what to knowElon Musk's team has quietly filed confidential paperwork with the SEC for what Bloomberg estimates could be a...Brownstone Research | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | Sponsored$30 stock to buy before Starlink goes public (WATCH NOW!)In the next 3 minutes… James Altucher – legendary investor and venture capitalist… And someone who’s kno...Paradigm Press | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredMy feud with Zohran MamdaniEmmy-winning analyst releases his next big story Whitney Tilson shocked the nation on 60 Minutes when he ac...Stansberry Research | SponsoredIran War Shock: What I Was Told In That Private MeetingYou’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...Banyan Hill Publishing | SponsoredWhy this tiny stock may move before the SpaceX IPO dropsThe projected SpaceX and xAI S-1 filing hits the SEC on June 1st - and analyst Dylan Jovine says $1.75 trillio...Behind the Markets | SponsoredSpaceX IPO hides a much bigger storyThe SpaceX IPO could be the biggest in history at $1.75 trillion - but the real story isn't the IPO itself. ...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Drugs Made In America Acquisition II Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Drugs Made In America Acquisition II With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.